TY - JOUR
T1 - Clinical and genetic analyses of a Dutch cohort of 40 patients with a nephronophthisis-related ciliopathy
AU - Stokman, Marijn F.
AU - van der Zwaag, Bert
AU - van de Kar, Nicole C.A.J.
AU - van Haelst, Mieke M.
AU - van Eerde, Albertien M.
AU - van der Heijden, Joost W.
AU - Kroes, Hester Y.
AU - Ippel, Elly
AU - Schulp, Annelien J.A.
AU - van Gassen, Koen L.
AU - van Rooij, Iris A.L.M.
AU - Giles, Rachel H.
AU - Beales, Philip L.
AU - Roepman, Ronald
AU - Arts, Heleen H.
AU - Bongers, Ernie M.H.F.
AU - Renkema, Kirsten Y.
AU - Knoers, Nine V.A.M.
AU - van Reeuwijk, Jeroen
AU - Lilien, Marc R.
N1 - Funding Information:
We thank the patients and their parents for participating in this research. We thank Jan Willem Deiman for designing the website www.kouncil.nl. We thank the following physicians for referring patients for inclusion into the Nephronophthisis Registry: M. G. Keijzer-Veen, M. J. H. van den Boogaard, A. van Zuilen, A. C. Abrahams, J. J. van Harssel, K. D. Lichtenbelt (UMC Utrecht), D. A. Hesselink, M. W. F. van den Hoogen (EMC Rotterdam), J. M. Cobben (AMC Amsterdam, St. George?s University Hospital London), M. H. Breuning, R. W. G. van Rooij (Leiden UMC), E. Levtchenko (KU Leuven), M. M. van Genderen (Bartimeus), J. B. G. M. Verheij, E. Zonneveld-Huijssoon, E. H. Gerkes (UMC Grongingen), and A. Eikelenboom (VUmc Amsterdam). The authors declare that they have no conflict of interest.
Funding Information:
Funding information The researchers received funding from the Dutch Kidney Foundation under grant agreements CP11.18 Kouncil (N. V. A. M. K., R. H. G., P. L. B., and H. H. A.), the European Community’s Seventh Framework Programme (FP7/2009) under grant agreement 305608 EURenOmics (N. V. A. M. K.), 150KG18 (K. Y. R.), and the NIHR Great Ormond Street Hospital Biomedical Research Center (P. L. B.).
Publisher Copyright:
© 2018, The Author(s).
PY - 2018/10/1
Y1 - 2018/10/1
N2 - Background: Nephronophthisis is an autosomal recessive ciliopathy and important cause of end-stage renal disease (ESRD) in children and young adults. Diagnostic delay is frequent. This study investigates clinical characteristics, initial symptoms, and genetic defects in a cohort with nephronophthisis-related ciliopathy, to improve early detection and genetic counseling. Methods: Forty patients from 36 families with nephronophthisis-related ciliopathy were recruited at university medical centers and online. Comprehensive clinical and genotypic data were recorded. Patients without molecular diagnosis were offered genetic analysis. Results: Of 40 patients, 45% had isolated nephronophthisis, 48% syndromic diagnosis, and 7% nephronophthisis with extrarenal features not constituting a recognizable syndrome. Patients developed ESRD at median 13 years (range 5–47). Median age of symptom onset was 9 years in both isolated and syndromic forms (range 5–26 vs. 5–33). Common presenting symptoms were fatigue (42%), polydipsia/polyuria (33%), and hypertension (21%). Renal ultrasound showed small-to-normal-sized kidneys, increased echogenicity (65%), cysts (43%), and abnormal corticomedullary differentiation (32%). Renal biopsies in eight patients showed nonspecific signs of chronic kidney disease (CKD). Twenty-three patients (58%) had genetic diagnosis upon inclusion. Thirteen of those without a genetic diagnosis gave consent for genetic testing, and a cause was identified in five (38%). Conclusions: Nephronophthisis is genetically and phenotypically heterogeneous and should be considered in children and young adults presenting with persistent fatigue and polyuria, and in all patients with unexplained CKD. As symptom onset can occur into adulthood, presymptomatic monitoring of kidney function in syndromic ciliopathy patients should continue until at least age 30.
AB - Background: Nephronophthisis is an autosomal recessive ciliopathy and important cause of end-stage renal disease (ESRD) in children and young adults. Diagnostic delay is frequent. This study investigates clinical characteristics, initial symptoms, and genetic defects in a cohort with nephronophthisis-related ciliopathy, to improve early detection and genetic counseling. Methods: Forty patients from 36 families with nephronophthisis-related ciliopathy were recruited at university medical centers and online. Comprehensive clinical and genotypic data were recorded. Patients without molecular diagnosis were offered genetic analysis. Results: Of 40 patients, 45% had isolated nephronophthisis, 48% syndromic diagnosis, and 7% nephronophthisis with extrarenal features not constituting a recognizable syndrome. Patients developed ESRD at median 13 years (range 5–47). Median age of symptom onset was 9 years in both isolated and syndromic forms (range 5–26 vs. 5–33). Common presenting symptoms were fatigue (42%), polydipsia/polyuria (33%), and hypertension (21%). Renal ultrasound showed small-to-normal-sized kidneys, increased echogenicity (65%), cysts (43%), and abnormal corticomedullary differentiation (32%). Renal biopsies in eight patients showed nonspecific signs of chronic kidney disease (CKD). Twenty-three patients (58%) had genetic diagnosis upon inclusion. Thirteen of those without a genetic diagnosis gave consent for genetic testing, and a cause was identified in five (38%). Conclusions: Nephronophthisis is genetically and phenotypically heterogeneous and should be considered in children and young adults presenting with persistent fatigue and polyuria, and in all patients with unexplained CKD. As symptom onset can occur into adulthood, presymptomatic monitoring of kidney function in syndromic ciliopathy patients should continue until at least age 30.
KW - Ciliopathy
KW - Clinical registry
KW - Gene-phenotype association
KW - Nephronophthisis
KW - Pediatric kidney disease
UR - http://www.scopus.com/inward/record.url?scp=85049567838&partnerID=8YFLogxK
U2 - 10.1007/s00467-018-3958-7
DO - 10.1007/s00467-018-3958-7
M3 - Article
AN - SCOPUS:85049567838
SN - 0931-041X
VL - 33
SP - 1701
EP - 1712
JO - Pediatric Nephrology
JF - Pediatric Nephrology
IS - 10
ER -